The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
The Mirror US on MSN
Fox News viewers label Karoline Leavitt a 'paid liar' after Biden blame-game on air
Fox News viewers are scrutinizing Press Secretary Karoline Leavitt after her visit to the network saw her throw inaccurate ...
Industrial policy is likely to be a key topic for discussion at the forthcoming 14th WTO Ministerial Conference (MC-14) in ...
The popular class of weight loss drugs known as GLP-1s have shown to be effective in curbing cravings beyond food. A few early studies have suggested that GLP-1 medications can do a lot to alleviate ...
FinanceBuzz on MSN
16 important documents you should always shred (not just throw away)
If you hope to avoid wasting money on preventable financial mishaps, here is a list of must-shred documents that you might have lurking in your house.
Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late ...
Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ...
Anthropic, maker of the chatbot Claude, declined to comment on the meeting but CEO Dario Amodei has made clear his ethical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results